|
|||||
|
|
The flawed basis for FDA post-marketing safety decisions: the example of anti-depressants and children. |
|
| Authors: | Donald F Klein |
| Affiliation: | New York State Psychiatric Institute, Columbia University, New York, NY 10032, USA. donaldk737@aol.com |
| Abstract: | |
| Keywords: | |